Alkermes plc - stock earnings
ALKS Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
May 1, 2024 AfterMarket | 0.44 / 0.62 | - | 350.4 million / 369.9 million | - |
ALKS Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | 112.8 million USD | 377.5 million USD |
2023Q3 | 47.8 million USD | 380.9 million USD |
2023Q2 | 237.1 million USD | 617.4 million USD |
2023Q1 | -41.8 million USD | 287.6 million USD |
2022Q4 | -28.3 million USD | 304.7 million USD |
2022Q3 | -64.0 million USD | 252.4 million USD |
2022Q2 | -30.1 million USD | 276.2 million USD |
2022Q1 | -35.9 million USD | 278.5 million USD |
2021Q4 | 873000 USD | 324.5 million USD |
2021Q3 | -29.0 million USD | 294.1 million USD |
2021Q2 | 2.4 million USD | 303.7 million USD |
2021Q1 | -22.4 million USD | 251.4 million USD |
2020Q4 | -42.6 million USD | 280.0 million USD |
2020Q3 | -134000 USD | 265.0 million USD |
2020Q2 | -29.4 million USD | 247.5 million USD |
2020Q1 | -38.7 million USD | 246.2 million USD |
2019Q4 | -5.4 million USD | 412.7 million USD |
2019Q3 | -52.9 million USD | 255.2 million USD |
2019Q2 | -42.0 million USD | 279.9 million USD |
2019Q1 | -96.4 million USD | 223.1 million USD |
2018Q4 | -9.7 million USD | 315.8 million USD |
2018Q3 | -34.4 million USD | 248.7 million USD |
2018Q2 | -32.6 million USD | 304.6 million USD |
2018Q1 | -62.5 million USD | 225.2 million USD |
2017Q4 | -9.8 million USD | 275.4 million USD |
2017Q3 | -36.3 million USD | 217.4 million USD |
2017Q2 | -43.0 million USD | 218.8 million USD |
2017Q1 | -68.9 million USD | 191.8 million USD |
2016Q4 | -21.1 million USD | 213.5 million USD |
2016Q3 | -62.7 million USD | 180.2 million USD |
2016Q2 | -47.2 million USD | 195.2 million USD |
2016Q1 | -77.4 million USD | 156.8 million USD |
2015Q4 | -69.4 million USD | 163.1 million USD |
2015Q3 | -81.0 million USD | 152.7 million USD |
2015Q2 | -46.1 million USD | 151.4 million USD |
2015Q1 | -30.7 million USD | 161.2 million USD |
2014Q4 | 30.5 million USD | 175.2 million USD |
2014Q3 | -40.0 million USD | 160.0 million USD |
2014Q2 | 3.7 million USD | 153.4 million USD |
2014Q1 | -24.4 million USD | 130.2 million USD |
2013Q4 | 18.1 million USD | 154.5 million USD |
2013Q3 | -7.8 million USD | 139.8 million USD |
2013Q2 | 7.3 million USD | 138.6 million USD |
2013Q1 | 3.0 million USD | 163.4 million USD |
2012Q4 | 16.3 million USD | 135.9 million USD |
2012Q3 | -16.7 million USD | 124.0 million USD |
2012Q2 | 22.4 million USD | 152.2 million USD |
2012Q1 | -63.4 million USD | 130.5 million USD |
2011Q4 | -14.8 million USD | 125.6 million USD |
2011Q3 | -22.3 million USD | 72.0 million USD |
2011Q2 | -13.2 million USD | 61.9 million USD |
2011Q1 | -13.1 million USD | 51.1 million USD |
2010Q4 | -11.4 million USD | 44.0 million USD |
2010Q3 | -7.7 million USD | 49.2 million USD |
2010Q2 | -13.4 million USD | 42.3 million USD |
2010Q1 | -13.9 million USD | 38.5 million USD |
2009Q4 | -6.8 million USD | 44.2 million USD |
2009Q3 | -8.7 million USD | 48.2 million USD |
2009Q2 | -10.2 million USD | 47.5 million USD |
2009Q1 | -13.6 million USD | 43.9 million USD |
2008Q4 | 112.7 million USD | 155.7 million USD |
2008Q3 | 1.7 million USD | 47.3 million USD |
2008Q2 | 29.7 million USD | 80.0 million USD |
2008Q1 | -18.3 million USD | 62.4 million USD |
2007Q4 | 168.9 million USD | 50.8 million USD |
2007Q3 | 7.7 million USD | 58.6 million USD |
2007Q2 | 8.7 million USD | 68.9 million USD |
2007Q1 | 3.5 million USD | 64.8 million USD |
2006Q4 | 2.9 million USD | 62.4 million USD |
2006Q3 | 3.7 million USD | 61.2 million USD |
2006Q2 | -715000 USD | 51.5 million USD |
2006Q1 | 4.4 million USD | 53.7 million USD |
2005Q4 | 1.4 million USD | 41.4 million USD |
2005Q3 | 11.8 million USD | 46.7 million USD |
2005Q2 | -13.7 million USD | 24.8 million USD |
2005Q1 | -14.5 million USD | 23.0 million USD |
2004Q4 | -9.0 million USD | 23.6 million USD |
2004Q3 | -14.3 million USD | 18.0 million USD |
2004Q2 | -36.1 million USD | 11.5 million USD |
2004Q1 | -24.7 million USD | 16.1 million USD |
2003Q4 | -20.9 million USD | 11.2 million USD |
2003Q3 | -26.2 million USD | 7.5 million USD |
2003Q2 | -30.6 million USD | 4.3 million USD |
2003Q1 | -35.0 million USD | 12.3 million USD |
2002Q4 | 41.2 million USD | 15.2 million USD |
2002Q3 | -67.8 million USD | 9.5 million USD |
2002Q2 | -45.3 million USD | 10.3 million USD |
2002Q1 | -22.5 million USD | 12.6 million USD |
2001Q4 | -17.9 million USD | 11.5 million USD |
2001Q3 | -12.6 million USD | 14.5 million USD |
2001Q2 | -8.3 million USD | 15.5 million USD |
2001Q1 | -11.0 million USD | 9.9 million USD |
2000Q4 | -7.4 million USD | 9.7 million USD |
2000Q3 | -8.3 million USD | 7.5 million USD |
2000Q2 | 9.8 million USD | 29.0 million USD |
2000Q1 | -28.1 million USD | -1.6 million USD |
1999Q4 | -17.2 million USD | 9.5 million USD |
1999Q3 | -14.4 million USD | 6.8 million USD |
1999Q2 | -8.3 million USD | 8.2 million USD |
1999Q1 | -31.2 million USD | 7.7 million USD |
1998Q4 | -2.2 million USD | 13.6 million USD |
1998Q3 | -2.6 million USD | 12.2 million USD |
1998Q2 | -5.1 million USD | 10.3 million USD |
1998Q1 | -1.8 million USD | 9.2 million USD |
1997Q4 | -3.0 million USD | 7.8 million USD |
1997Q3 | -959554 USD | 8.4 million USD |
1997Q2 | -4.0 million USD | 5.9 million USD |
1997Q1 | -4.8 million USD | 5.8 million USD |
1996Q4 | -4.2 million USD | 5.5 million USD |
1996Q3 | -4.8 million USD | 4.1 million USD |
1996Q2 | -4.9 million USD | 4.4 million USD |
1996Q1 | -5.5 million USD | 4.3 million USD |
1995Q4 | -2.8 million USD | 3.1 million USD |
1995Q3 | -3.0 million USD | 3.1 million USD |
1995Q2 | -2.5 million USD | 3.5 million USD |
1995Q1 | -3.2 million USD | 3.5 million USD |
1994Q4 | -1.9 million USD | 3.6 million USD |
1994Q3 | -3.1 million USD | 3.0 million USD |
1994Q2 | -3.7 million USD | 2.3 million USD |
1994Q1 | -3.9 million USD | 1.6 million USD |
1993Q4 | -5.0 million USD | 1.3 million USD |
1993Q3 | -3.7 million USD | 2.7 million USD |
1993Q2 | -4.7 million USD | 2.3 million USD |
1993Q1 | -35.0 million USD | 2.8 million USD |
1992Q4 | -2.1 million USD | 2.7 million USD |
1992Q3 | -2.1 million USD | 2.0 million USD |
1992Q2 | -900000 USD | 2.1 million USD |
1992Q1 | ? USD | 700000 USD |
1991Q4 | ? USD | 700000 USD |
1991Q3 | -1.6 million USD | 100000 USD |
1991Q2 | -1.9 million USD | 100000 USD |
ALKS Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 355.8 million USD | 1.7 billion USD |
2022 | -158.3 million USD | 1.1 billion USD |
2021 | -48.2 million USD | 1.2 billion USD |
2020 | -110.9 million USD | 1.0 billion USD |
2019 | -196.6 million USD | 1.2 billion USD |
2018 | -139.3 million USD | 1.1 billion USD |
2017 | -157.9 million USD | 903.4 million USD |
2016 | -208.4 million USD | 745.7 million USD |
2015 | -227.2 million USD | 628.3 million USD |
2014 | -30.1 million USD | 618.8 million USD |
2013 | 17.6 million USD | 432.9 million USD |
2012 | 25.0 million USD | 575.5 million USD |
2011 | -113.7 million USD | 390.0 million USD |
2010 | -45.5 million USD | 186.6 million USD |
2009 | -39.6 million USD | 178.3 million USD |
2008 | 130.5 million USD | 326.8 million USD |
2007 | 167.0 million USD | 240.7 million USD |
2006 | 9.4 million USD | 240.0 million USD |
2005 | 3.8 million USD | 166.6 million USD |
2004 | -73.9 million USD | 76.1 million USD |
2003 | -102.4 million USD | 39.1 million USD |
2002 | -106.9 million USD | 47.3 million USD |
2001 | -61.4 million USD | 54.1 million USD |
2000 | -16.9 million USD | 56.0 million USD |
1999 | -68.0 million USD | 22.9 million USD |
1998 | -41.1 million USD | 43.7 million USD |
1997 | -9.8 million USD | 31.3 million USD |
1996 | -18.8 million USD | 19.8 million USD |
1995 | -13.7 million USD | 14.0 million USD |
1994 | -11.9 million USD | 12.3 million USD |
1993 | -17.3 million USD | 7.8 million USD |
1992 | -40.1 million USD | 9.5 million USD |
1991 | -8.1 million USD | 1.7 million USD |
ALKS
Price: $24.01
52 week price:
Payout Ratio Range:
Earnings Per Share: 3.06 USD
P/E Ratio: 22.03
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 283127
Ebitda: 39.2 millionMarket Capitalization: 4.4 billion